Amoxicillin
Product Images NDC 50090-0711

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Amoxicillin (NDC 50090-0711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Amoxicillin 875 Hikma 1)

The given text provides the dosing recommendations for adult and children of different age groups for various types of infections. The dosage varies for different body parts and severity of the infection. The text also includes a note for not using the mentioned regimen for children under 2 years of age. The dosing guidelines are not available for infections caused by bacteria that are intermediate in their susceptibility to amoxicillin. The dosage should be adjusted based on the weight of the individual.*

FDA Label Image

Chemical Structure (Amoxicillin 875 Hikma 2)

FDA Label Image

Table 3 (Amoxicillin 875 Hikma 3)

This is a pharmacokinetic study presenting mean values of amoxicillin's absorption and distribution parameters in healthy adults. The study administered a 400mg dose of amoxicillin in two different forms (suspension and chewable tablets) and calculated its AUC and Cha values. The results suggest that chewable tablets had higher AUC values than the suspension form. The peak concentration of amoxicillin was observed around one hour after administration.*

FDA Label Image

Bacteria (Amoxicillin 875 Hikma 4)

This text is describing different types of bacteria divided into two categories: Gram-Positive and Gram-Negative Bacteria. Under each category, specific types of bacteria are listed, including Enterococcus faecalis, Staphylococcus spp., Streptococcus pneumoniae, α and β-hemolytic streptococci for Gram-Positive Bacteria, and Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, Proteus mirabilis, and Helicobacter pylori for Gram-Negative Bacteria.*

FDA Label Image

Table 4 (Amoxicillin 875 Hikma 5)

FDA Label Image

Table 5 (Amoxicillin 875 Hikma 6)

Table 5 shows the acceptable quality control ranges for Amoxicillin against different bacteria strains. The range of minimum inhibitory concentration (MIC) and disk diffusion zone are provided for Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae. The strains are identified by their ATCC number, where ATCC stands for American Type Culture Collection.*

FDA Label Image

Table 6 (Amoxicillin 875 Hikma 7)

This is a table showing the eradication rates of H. pylori bacteria when Amoxicillin is included in a triple therapy regimen. It includes two studies, each with the number of patients treated, and the success rates of the therapy analyzed both in evaluable and intention-to-treat cases. The table also includes confidence intervals for each success rate. Additional information is provided on the specifics of patient inclusion in the analyses.*

FDA Label Image

Table 7 (Amoxicillin 875 Hikma 8)

FDA Label Image

Label Image (Lbl500900711)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.